Omni Health, Inc.
OMHE · OTC
1/31/2017 | 10/31/2016 | 7/31/2016 | 4/30/2016 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 14.4% | 149.9% | 436.8% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 27.1% | 29.6% | 24.4% | -3.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -3.4% | 2.8% | -4.7% | -441.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | $1 | -$0 |
| % Margin | -6.1% | -3% | 199.9% | -441.8% |
| EPS | -0 | -0 | 0.001 | -0.001 |
| % Growth | -123.2% | -103.2% | 275% | – |
| EPS Diluted | -0 | -0 | 0.001 | -0.001 |
| Weighted Avg Shares Out | 972 | 855 | 755 | 513 |
| Weighted Avg Shares Out Dil | 972 | 855 | 755 | 513 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -2.7% | 3.4% | 0.9% | -441.4% |